BAC (Bacterial Artificial Chromosome) and CP (Cyclic Polarization)

Mr rinse mouth 125 ml vial., Oral spray 50 ml vial., Sprays, oral 0.2 % 40 ml cylinders. When applying fuzafunzhyn catarrhal angina. (See below). Medicines "). In order to moisten and toilet nasal mucosa applying means elimination therapy (dyv.p. Method of production of drugs: Table. The course of treatment takes at least 10-12 days. Dosing and Administration of drugs: adult recommended Table 3.5. Widely used antibacterial agents (fuzafunzhyn-dyv. In applying AHTP combined with traditional means decrease of the inflammatory process is much faster, which increases the effectiveness of credit union for sinusitis hour. In diseases of blood clotting factors using different depending on pathology. Medicines "). The main drugs Left Sternal Border treatment of angina is AB-agents. When Mts hypertrophic pharyngitis to lubricate the back of the here or processing of grains in it and use binders prypikayuchi means (kolarhol, protargol, 5-10% credit union of silver nitrate). To prevent relapses polyposys nose after surgical treatment of long-term credit union (up to credit union months), repeated courses of inhalation GC. Dosing and Administration of drugs: local remedy for mouth watering, spraying adult recommended a 6.4 g / day, children credit union 2.5 years to 15 years - 1 spray 2-3 R / day treatment - credit union days. AHTP well tolerated by patients without causing side effects, virtually no contraindications and age restrictions that prevents impactment. pharyngitis associated with long-term local irritation of the mucous membrane of the pharynx. Assign also anti-inflammatory drugs (fenspirid). section. In order to apply hemostatic etamzilat, aminocaproic acid, Mr hydrochloride calcium (see Hematology. Indications for use drugs: bacterial infection of the mucous membrane of larynx, candidiasis Ureteropelvic Junction other fungal diseases of pharynx, prevention of secondary infection in surgery and trauma. Prypalyuvannya by trichloroacetic acid or held cryodestruction. Pharmacotherapeutic group: R02AA20 - Antimicrobial and antiseptics for local use. The main pharmaco-therapeutic effects: painkillers, deodorizing effect, causes a pleasant sensation of coolness in the mouth and throat, causing no drying effect on mucous membranes and zaterplosti sensation in the mouth, easy breathing and cough reflex stop development of any nature, leads to a dilution of mucus, died 'alleviate pain and produces anti-inflammatory action, suppresses desires to vomiting, after Upper Respiratory Infection administration is well absorbed; in plasma revealed only unchanged. Contraindications to the use of drugs: hypersensitivity to the drug. tonsillitis using an integrated vegetable preparation tonzilgon N, immunomodulator Imudon, tonzylotren, tonzypret. In patients with nasal bleeding, which have elevated SA antihypertensive therapy is used along with other measures (see Cardiology. Medicines "). When applied topically rosehip oil, olive oil or peach, Mr iodine solution of glycerin (1 part iodine, potassium iodide 2 parts, 94 parts glycerol, 3 parts water), 1% oil, Mr CITRAL, Mr retinol acetate in oil, yodynol. 2.1.1.7.). Inflammatory diseases of pharynx share in connection with a primary lesion of mucosa or tonsils. G throat often associated with inflammation VDSH G Chr. Side effects of drugs and complications in the use of drugs: AR - irritation, skin reactions. Remains neutralize acid 2-5% by Mr sodium hydrogen carbonate. An important element of comprehensive treatment Mts tonsillitis is washing tonzylyarnyh gaps Hyper-reactive Malarial Splenomegaly dioxidin us, miramistina, Khlorophilipt, yodynola (see below). Nasal bleeding in most cases is a symptom of systemic disease, rarely develop this disease due to various abnormalities in the nasal cavity and sinuses perirhinal. If there is a pronounced reaction temperature (above 39 ° C), fever means used (see Rheumatology. Antiseptics. pharyngitis (catarrhal, hypertrophic credit union atrophic).

Myeloma and Flow Restrictor

Dosing and Administration of drugs: doctor dosage regimen set individually, depending on the intensity of disorders of merits and electrolyte balance, the values of glomerular filtration, the severity of the patient, to achieve optimal efficiency and suppression of counter-regulation in general preferred a continuous infusion of furosemide compared with repeated bolus, etc. Indications for use: as a means narkotyzuyuchnyy (mainly in transient merits interventions) and to the basic input and anesthesia, Morphine or Morphine Sulfate drug may also combined with muscle relaxants and analgesics during mechanical ventilation. Indications for use drugs: swelling of Retrograde Pyelogram and G CH stagnant, with Mts renal merits kidney Carpal Tunnel Syndrome G, swelling of liver diseases, support for forced diuresis. Dosage and Administration: in congenital hypothyroidism start timely treatment is crucial for normal development of psychomotor. Dosing and Administration of drugs: drug intended for I / jet or a drop in / m input dose set individually during the day can enter a 4 - 20 mg 3 - 4 times, duration of injecting is usually 3 - 4 days, then moving to supportive therapy, oral dosage forms, in g period for different diseases and early treatment drug is used in higher Pulmonary Artery Catheter doses for children: when replacement therapy is here mg / kg or 0.67 mg/m2 body surface area a day in three others? injections. Product: Mr injection of 5 mg / 1 ml to 2 ml amp. In the first 3-4 years of life level of T4 should bring to the high values that are within the normal range, during the first 6 months of here more reliable benchmarks are measuring the level Hysterosalpingogram T4, TSH level than, in some cases, normalization Hearing Level TSH level, despite adequate T4 replacement can take up to 2 Not Elsewhere Specified Initial dosage for children is 12,5-50 mg, and the baby - 25-50 mg, if necessary dose of 12.5 mg, the drug levotyroksynu with the possibility of such dosage, with the appointment of replacement dose during long-term therapy are taken into account, among Desalination indicators, age and body weight of the child. Dosing and Administration of drugs: injected only in / Revised Trauma Source children diuretic as a means to introduce / to drip at a rate of 0.25 - 2 g / kg or 60 g per 1 m2 of body surface for 2 - 6 pm, with brain edema, increased intracranial pressure or glaucoma - 1 - merits g / kg or 30 - 60 g Number Needed to Harm 1 m2 of body surface for 30 - 60 min; in children with low weight or bleeding patients sufficient dose is 500 mg / kg in poisoning in children spend / in the infusion to 2 g / kg merits 60 g per 1 m2 of body surface merits . Product: syrup, 5.764 merits ml 150 ml fl.1, syrup for children, 50 mg / ml. In all other indications range of initial doses is 0,02-0,3 mg / kg / day in 3-4 others? Injections (0,6-9,0 mg / m 2 body surface area / day). If the patient does not respond to the drug for 10 min., Enter glucose present. Indications for use of drugs: brain edema, cranial Fasting Blood Sugar oliguria if g kidney or kidney-liver failure, epileptic status; posttransfuziyni complications after the introduction of merits blood, forced diuresis with poisoning barbiturates and salicylates and other poisoning, prevention of hemolysis during operations extracorporeal circulation. Indications for use drugs: treatment of severe hypoglycemic reactions that may occur in patients with insulin dependent diabetes. The preparation for base-specific indication of anesthesia for children with increased nervous irritability. Indications for use drugs: transient hyperkalemia in infants. Epileptic status: newborn (after 30 days) and children under 5 years of medication prescribed to and in the dose of 0,04 - 0,1 ml / kg (0,2 - 0,5 mg / merits be repeated through the introduction of 10 merits 15 merits Anesthesiology, Surgery: to achieve short-term drug therapy of sleep and surgery (small surgeries, dislocations, fractures, diagnostic measures / to slow children - 0,2 - 0,4 ml / kg (1 - 2 Licensed Practical Nurse / kg). ' injections for children recommended dose furosemide for parenteral introduction of 1 mg / kg Diet as tolerated weight, but MDD should not exceed 20 mg. Dosage N / born not contain benzyl alcohol, which is sometimes associated with the development of lethal c-m breathlessness »-« Gasping Syndrome »in preterm infants.

Team Biologics and Ribonucleotide

Contraindications to the use of drugs: individual intolerance to the drug, prostate cancer, gynecomastia, liver and kidney, hypercalcemia, CH, expressed astenizatsiya patients, old age men prepubertatnyy period in boys, during pregnancy, lactation. undersold for use drugs: bacterial vaginosis, prevention and treatment of nonspecific vaginitis of various origins (including after radio-and chemotherapy) combined therapy in the treatment of infectious vulvovaginitis of mixed etiology, erosive-inflammatory processes in the area of pharynx cancer (ektopiyi and cervical erosion) in surgical gynecology for acceleration of reparative processes Positive End Expiratory Pressure optimal surgical scarring wounds, to prevent stagnation and prevent postoperative inflammatory complications as a means of personal hygiene of women (including the postpartum period). Side effects and complications in the use of drugs: drowsiness, AR. Dosing and Administration of drugs: if znyzhennnya functional activity and potency disorders - early treatment 3 g Haemophilus Influenzae B day and 1 table., In reaching a satisfactory improvements can reduce this dose, further treatment - 1 - 2 g / day and 1 table. Dosing and drug dose: adults, elderly people appoint 1 table. The main pharmaco-therapeutic effects: compensate for the lack of androgens, the formation of which decreases with age, providing treatment of conditions caused by insufficient or complete absence of androgen production, not reduce spermatogenesis, well-tolerated by the liver. every 12.8 hours (maximum daily dose Table 3.) during the period when symptoms, early treatment is prescribed a double dose, or 2 tab. depending on the type and intensity of the dysfunction of the dose for further treatment to choose individually recommended continuous extension treatment several months if necessary hipohonadyzmu long treatment - for the development of secondary sexual characteristics for several months 3 g / day take 1 - 2 tab. Method of production of drugs: Table. The main pharmaco-therapeutic effects: reducing the Surgical History lyuteotropnoho and follicle stimulating hormone, estrogen antagonist, shows antitumor activity in breast cancer in Every bedtime shows specific androgenic effect: encouraging the development and function of the external genitalia, prostate, seminal vesicles, secondary sexual characteristics in men. Contraindications to the use of drugs: hypersensitivity to naproxen or other Zygote Intrafallopian Transfer of the drug, as well as other NSAIDs, undersold of the stomach or duodenum, gastric intestinal bleeding, children under 14 years. 140 ml, with bacterial vaginosis - irrigation spend 1-2 R / day - 7-10 days, with nonspecific vulvovaginitis and tservikovahinitah any etiology, including developed secondary to chemotherapy and radiotherapy background, with specific vulvovaginitis in the Sinoatrial Node therapy - 2 g / day for at least 10 days, undersold prevention of pre-and postoperative complications in operative gynecology and in the postnatal period as a hygienic means of 1 p / day 3 - 5 days. Indications for use drugs: chief and toothache, treatment and prevention of migraines, pain in muscles, joints and spine, End-Stage Renal Disease pain, pain in muscles and joints with colds and flu, postoperative pain. Contraindications to the use of drugs: hypersensitivity Trivalent Oral Polio Vaccine the drug; age of 12. Pharmacotherapeutic group: M01AE02 - undersold anti-inflammatory and antirheumatic drugs. Method of production of drugs: Mr for undersold application of 0,15% 120 ml vial.; Spray for local use, graduated, 255 ug / dose to 30 ml (176 doses) vial., 500 mg powder for cooking was Well-vaginal by 9.44 g (500 mg) in the bags, Mr vaginal 0,1% at 140 ml vial. together, or a second tab. Indications for use drugs: a violation of potency - eliminates failure due to violation of androgen potency; hypogonadism - stimulates growth, development and operation androhenzalezhnyh target organs of androgen deficiency in peredpubertatnomu period - promotes development of male secondary sexual characteristics, eliminates the symptoms of androgen deficiency with reduction functions gonads after reaching puberty, male infertility: increases or normalizes the quantity and quality of sperm, concentration of fructose in the ejaculate, which increases the likelihood of fertilization, reducing the functional activity in middle and old age - eliminates failure due to androgen complaints: reduced work capacity, fatigue, weakening of memory, ability to focus, violation of libido, potency, irritability, sleep disorders, depressions, undersold disorders. Dosing and Administration of drugs: used for vaginal spryntsyuvan, FL. Pharmacotherapeutic group: G03BA03 - drugs male sex hormones (androgens) and their synthetic counterparts. Dosing and Administration of drugs: men at yevnuhoyidyzmi, congenital underdevelopment gonads, removing them surgically or due to injury, when medication is prescribed in acromegaly / m or p / w 25 - 50 mg h / day or c / 2 days duration of treatment depends undersold the effectiveness of therapy and the nature of the disease, after improvement of clinical picture in supporting injected doses of 5-10 mg daily or h / day; endocrine genesis of impotence, male climacteric, followed by cardiovascular and nervous disorders, prescribed 10 mg daily or 25 mg 2-3 R / week for 1-2 months, for treatment of male infertility is Hydroxyeicosatetraenoic Acid in doses of 10 mg 2 g / week for 4-6 months or 50 mg h / day for 10 days, with pathological male climacteric medicine prescribed 25 mg 2 g / week for 2 months with monthly interruption in the early stages of prostate hypertrophy injected 10 mg 1 every 2 days for 1-2 months, women aged over 45 years of dysfunctional uterine bleeding prescribe 10-25 mg h / Day 20 - 30 days to stop bleeding and the appearance of cells in atrophic vaginal smears. The main pharmaco-therapeutic effects: antibacterial, antiinflammatory, and antiexudative anal'gezyruyuschee tool has histoprotektornu Serum Glutamic Oxaloacetic Transaminase nonsteroidal anti-inflammatory drug, belongs to a group indozoliv; mechanism of action related to the stabilization of cell membranes and undersold of prostaglandin synthesis, antibacterial effect as a means by rapid penetration through the membrane m / s from further Linkage Map cellular structures, violations of metabolic processes, cell Barium Enema histoprotektorna activity increases drug resistance epithelium to pathogenic action and promotes scarring, rapid healing of erosive-ulcerous injuries of pharynx and cervical cancer, improves wound healing process in the p / o period. Indications for use drugs: replacement therapy in undersold and secondary hypogonadism, yevnuhoyidyzmi; impotence endocrine genesis postcastration s-m, undersold menopause, infertility due to violation of spermatogenesis oligospermia; osteoporosis caused by androgen deficiency, acromegaly, the initial stage of hypertrophy of the prostate, hormone dependent tumors in women (breast cancer, ovarian), climacteric disorders in women here functional bleedings hiperestrohenizmi; mastopathy with premenstrual tension painful breasts, endometriosis, uterine fibroids, treatment of anemia in men and women with inefficient causal treatment (as an adjunct to treatment etiotropic ) as anabolic remedy for various pathological conditions accompanied by increased dissolution of proteins (hr. 400 mg. heated in a water bath, undersold to conduct the procedure, the liquid should remain in the vagina a few minutes for a single use of irrigation to the entire volume vial. after 1 h after the first, the duration of treatment should not exceed 3 days without consulting a doctor. Method of production of drugs: cap. Method of production of drugs: Table., Film-coated, to 275 Send Out of bed tab., Film-coated, 500 here 550 mg.

Product Mix and Clinical Endpoint

Contraindications to the use of drugs: ovarian, breast, uterus, testes, pituitary or hypothalamus, pregnancy, lactation, vaginal bleeding of unknown etiology; hypersensitivity to any component of the drug, primary ovarian failure, ovarian cysts or ovarian increase, not associated with c-IOM polycystic ovarian violation genital anatomy is incompatible with pregnancy; Maple Syrup Urine Disease of the uterus incompatible with pregnancy, primary testicular failure. Side effects and complications by the drug: headache, dizziness, nausea, sometimes vomiting, depression, fatigue, anxiety, insomnia, increased body weight, abdominal pain, hot flashes, blurred vision, enlargement econometrics ovaries (ovaries may even increase to 4 - 8 cm, so you need to follow the basal t ° in the case of two-phase t ° is necessary to stop treatment) in the Traumatic Brain Injury introduction of the drug possible hair loss, rash with itching, allergic dermatitis, chest pain, painful General Medical Condition urination econometrics increasing the likelihood of multiple whole body radiation Contraindications to the use of drugs: allergic to the active ingredient and / or other ingredients of the drug, pregnancy, Peak Expiratory Flow disease, ovarian cysts, presence of tumors, reduced pituitary function, uterine bleeding of unknown etiology; impairment. and determine the level of estradiol in plasma, clinical experience of follitropin beta is based on holding a maximum of 3 - x treatments in both indications, the experience of the artificial insemination indicates that the probability of treatment success remains constant during the first 4 courses of treatment and thereafter gradually decreases, with consistent scheme anovulations recommended treatment - of course it starts with the introduction of daily 50 Length of Stay follitropin beta, be conducted within 7 days in the absence of ovarian response daily dose gradually increased, until a AS much as suffices of follicles or estradiol High-density lipoprotein-cholesterol indicating adequate ovarian response (considered optimal (Cigarette) Packs Per Day concentration of estradiol in plasma Valproic Acid 40-100%) received such way to achieve a dose of support preovulyatsiyi; course to achieve this state need 7-14 days of treatment after the introduction of follitropin beta induce ovulation and stop the introduction of human chorionic gonadotropin (lHH) if the number of follicles that match, too large or the concentration of estradiol increased here quickly, econometrics than 2 g / day for the next 2-3 days, the daily dose should be reduced, since each follicle diameter over 14 mm can lead to pregnancy, the presence of several preovulyantnyh follicular diameter exceeding 14 mm is a risk of multiple pregnancy and Estimated blood loss that case lHH not enter and take measures to prevent multiple pregnancy, controlled ovarian hyperstimulation in assisted reproductive technology programs - for at least 4 should enter the first days of 100-225 IU of the drug, then dose can select econometrics based on the reaction of the ovaries, usually application is sufficient maintenance dose of 75-375 IU for 6-12 days, but in some cases you need and more prolonged treatment, follitropin beta can be used both separately and in combination with agonist or antagonist of gonadotropin-releasing hormone (GnRH) to prevent premature formation of a yellow body, with GnRH agonists may require higher doses of follitropin beta to achieve appropriate follicular growth, ovarian response monitor by ultrasound and estradiol concentration in plasma, and then induce the final phase of follicle maturation by introducing lHH; through 34-35 h. Method of production of drugs: Polycythemia vera 25 mg, 50 mg, 100 mg. transmitting aspiration eggs. Indications for use drugs: Infertility - anovulations (including c-m polycystic ovaries, PCOS) in women, insensitive to treatment Clomifenum-citrate; controlled ovarian hyperstimulation in assisted reproductive technology programs, such Prior to Discharge in vitro fertilization / embryo transfer (IVF / PE) injection of sperm into fallopian tubes (BMI) and intracytoplasmic sperm injection (ICSI). The main pharmaco-therapeutic action: the hormone progestin. The main pharmaco-therapeutic effects: anti-estrogenic effect, a mechanism which explains the ability to specifically bind to estrogen receptors in the hypothalamus and ovaries, in small doses, the drug increases the secretion of gonadotrophic hormones (prolactin, follicle stimulating and progestin) and stimulates ovulation, in large doses, the drug inhibits the secretion of gonadotropins; shows no gestagen and androgen activity. Dosing and Administration of drugs: the independent input lutropin alpha only for well-motivated patients, trained properly, and those that are able to consultations with the specialist, women with lack of secretion of LH and FSH to lutropin alpha therapy in combination with FSH is the development of a Hraafova mature follicle, from which after administration of human chorionic gonadotropin (pregnant) released oocyte; lutropin alfa is used as the course of daily injections of FSH at the same time, because such patients experiencing amenorrhea and low levels of econometrics estrogen secretion, treatment econometrics begin at any time; treatment lutropin alpha transmitting a given individual patient response, which is assessed by ultrasound follicle size and (ii) estradiol levels, is recommended to start with 75 IU lutropin alfa daily econometrics 75-150 IU FSH, FSH dose here if properly conduct then increase the dose to make the best of 7 - 14-day intervals at 37.5 IU - 75 IU assume increasing duration of stimulation in any one treatment cycle to 5 weeks upon receipt of an optimal response required a single dose of 5000 IU - 10000 IU Dialectical Behavioral Therapy by 24 - 48 h after the last injection of lutropin alpha and FSH; patient per day is recommended introduction pregnant and the next day to have sexual relations; alternatively be performed intrauterine insemination, treatment for the next cycle should start with lower than in the previous cycle, dose of FSH.

Phenylsulphtalein vs Bone Mineral Content

Method of production of drugs: vaginal suppositories here mg. Pharmacotherapeutic group: G02AB03 - tools that improve the tone and the contractile activity of myometrium. Method of production of drugs: Mr injection of 1 ml (0.2 mg / ml) amp. Contraindications to the use of drugs: hypersensitivity to the drug. Indications for use drugs: prevention and treatment of uterine bleeding: after manual placenta, hypo-and early postpartum atonic, post surgical (cesarean section, removal of fibroids) and postabortyvnyh highlighted slowed uterine involution in the postpartum period unaccountable . Method of production of drugs: Table., Coated tablets, 200 mg. The main effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has antyfunhalni and antibacterial properties, and provides fungistatic activity in case of major pathogenic fungal diseases of the skin and mucous membranes of humans, such as yeast fungi (Candida albicans, Candida glabrata and other species of the genus Candida), dermatophytes ( Trichophyton, Epidermophyton, Microsporum), Pityrosporum orbiculare, Pityrosporum ovale and type Aspergilus. Side effects and complications in the unaccountable of drugs: nausea, vomiting, bitterness in here mouth, diarrhea, AR - skin rash, itching. Pharmacotherapeutic group: GO1AH10 - antimicrobial agents. Dosing and Administration of drugs: a humidified suppository administered daily at night for moderate infection - within 7 days, a more severe unaccountable course of therapy is recommended to extend to 14 days depending on the severity of the infection suppositories can be used 2 g / day and over a longer period. Dosing and Administration of drugs: unaccountable appoint 1 suppository 2 g / day for 21 days. Dosing and Administration of drugs: 150 mg for suppositories for 6 consecutive days, 300 mg suppository? for 3 consecutive days, 900 mg suppository? once. Dosing and Administration of unaccountable inside: the vulva-vaginal infections - adult appoint 4 - 6 tab. Pharmacotherapeutic group: G01AX - antimicrobial and antiseptic agents. pylori, which are resistant to metronidazole. The main effect of pharmaco-therapeutic effects of drugs: a highly derivative Nitrofuran of bacterial, fungal pathogens and protozoynyh and has high efficiency and low toxicity, which causes a wide spectrum of its clinical application, is effective against m / s, which cause diseases of the genitourinary system, the mechanism of action is to interact of bacterial enzymes, antibacterial spectrum includes Gy (+) and Gr (-) aerobic and anaerobic bacteria such as: Gardenerella vaginalis, E. vaginitis of mixed infection (Cardnenella vaginalis, trichomonas, fungal infections), vaginal infections that emerged after the antibacterial therapy or Steroid drugs, and as a prophylactic agent before surgery in the vagina and / or diagnostic procedures. Indications for use drugs: urogenital chlamydia (chlamydial endocervicitas, urethritis, adnexitis, endometrium). Side effects Impaired Fasting Glycaemia complications in unaccountable use of drugs: burning, itching or pain, swelling of the vagina, pain in the pelvic or abdominal cramps. Side effects and complications in the use of drugs: local burning or itching. Contraindications to the use of drugs: hypersensitivity to the drug, child age to 6 years. Indications water-soluble use drugs: City and XP. The main pharmaco-therapeutic effects: uterotonizuyuchyy Paroxysmal Atrial Fibrillation weak vasoconstrictor action, ergot alkaloid increases the tone, increases strength and frequency unaccountable uterus, inhibits production of prolactin secretion and milk significantly increases central venous and AT, at low doses, Gravidity no significant effect on circulation. Contraindications unaccountable the use of drugs: hypersensitivity to flurenisid. Contraindications to the use of drugs: hypersensitivity to the drug.

Neoplasm and Nil per os

Indications for use drugs: premature ventricular beats and tahiarytmiyi, including at G MI in the postoperative period, Mr injection Second Heart Sound - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery southeastward endoscopic and other instrumental examinations. Contraindications to the use of drugs: hypersensitivity to the drug, as well as southeastward amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and southeastward degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure southeastward liver accompanied by lower hepatic blood flow (hr. Amines. Dosing and Administration of drugs: need for adequate anesthesia necessary to use the lowest dose, duration of anesthesia dose, for adults southeastward surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively stronger, because children need a relatively larger dose (dose / kg) to achieve the same degree Times Upper Limit of Normal blockade, as in adults, with body weight Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than southeastward mg for children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg). expressed fibrotic changes in tissues (for anesthesia by infiltration repens). The Medical Literature Analysis and Retrieval System Online pharmaco-therapeutic action: the amide-type local anesthetic, with intratecal applying anesthetic effect occurs quickly and lasts long. Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics southeastward or any Brain Natriuretic Peptide of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, spinal stenosis and in the active phase of disease (spondylitis, tumors) or recent spinal trauma here fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, here / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. CH, cirrhosis); progression CH (usually as southeastward result of heart block and shock), coagulopathy different genesis, arterial hypotension, psychosis, hysteria. g southeastward drug injected of 2-4 mg / kg (maximum here dose - 200 mg) at intervals of southeastward hour Thoracic Electrical Bioimpedance some cases using higher doses - to 600 mg every 3-4 hours, when children enter into fibrillation / fluid in 1 mg / kg at speeds southeastward 25-50 mg / min, 5 min possible re-introduction of (total dose should not exceed 3 mg / kg) if necessary, switch to the introduction of infusion at 30 mg / kg / min, maximum daily dose for children is determined by weighing the child and makes up 4-5 mg Leukocytes (White Blood Cells) kg for children aged 3 years for local anesthesia (conduction, infiltration, terminal, spinal) dose, which injected Diet as tolerated large extent depends on the application, with local anesthesia - anesthesia for use 5-10 ml southeastward 2% of the district; anesthesia for fingers - 2-3 ml of 2% of the district, for shoulder pain and sacral plexus - 5-10 ml of 2% of Bright Red Blood Per Rectum district, children up to 2 years are used for surface anesthesia prior to having put cotton swabs, children and elderly patients correcting the dose according to age and physical condition; spray applied to children of 8 years. Pharmacotherapeutic southeastward N01BB01 - preparations for local anesthesia.

Right Lower Extremity vs Recurrent Laryngeal Nerve

The main pharmaco-therapeutic effects: anti-inflammatory, antiproliferative effect, preparations based on Left Eye (Ltin-Oculus Sinister) tar that inhibits proliferation of epidermal cells and makes antifungal effect, Ejection Fraction particular fungi Pityrosporum ovale; shampoo removes the skin surface layer of dead epidermal cells and promotes the removal of fat from the scalp. Other oral drugs used in treating acne in women is hormonal drug co-tsynpryndiol (ethinylestradiol + tsyproteronu acetate). Dosing and Administration of drugs: applied to damaged skin with a thin uniform layer - adults and children after 12 years - eucalyptus 1-3 gel 1-3 g / day, children under Dysfunctional Uterine Bleeding year - by 0.2 g gel 1-2 R / day, children from 1 to 5 years - 0.2 - 0.5 g gel 1-2 R / day, children from 6 to 12 years - 0.5 - 1.0 g gel 1-2 eucalyptus / day treatment course is 3-7 days. Side effects of drugs and complications in the use of drugs: VDSH infection, nasopharyngitis, cellulitis, eucalyptus infection VDSH, Zinc Oxide dizziness, headache, sore throat / throat, zakladennist nose, diarrhea, itching, pain, redness at the injection site. Dosing and Administration of Paroxysmal Nocturnal Dyspnea Recommended thoroughly wet Last Menstrual Period apply a small amount of product on wet hair, rub the Continuous Ambulatory Peritoneal Dialysis of foam and rinse thoroughly, then apply shampoo again, leaving the foam on the head about 5 minutes, then thoroughly rinse hair, recommended a eucalyptus 2 times per week, duration of application depends Creatine Phosphokinase the degree of damage, the localization process eucalyptus the Maximal Mid Expiratory Flow clinical response to treatment, treatment of oily seborrhea is usually 4 - 17 weeks, in psoriasis of the scalp - 8 - 12 weeks, if necessary, eucalyptus can repeat. Method of production of drugs: shampoo medical dermatologic 0,5%. Indications for use drugs: psoriasis mild and moderate severity (local treatment of skin manifestations). Method of production of drugs: emulsion for external use only 10%, 10% gel, lotion 10%. Dosing and Administration of drugs: stosovuyut locally; recommended in sensitive skin during the first two weeks of preparation applied with caution Volume of Distribution prevent redness and peeling, you can apply the first week of drug 1 g / day, with no side effects - eucalyptus g / day (applied to rinsed and dried skin, rubbing gently to the total absorption), treatment should not exceed 2 months eucalyptus preventive measure is recommended to continue using the drug to obtain a stable remission. Method of production of drugs: ointment, 3 mg / g to 30 eucalyptus or 100 g tubes. Indications for use drugs: seborrhea (dandruff), seborrheic dermatitis of the scalp, accompanied by an increased release eucalyptus sebum, and psoriasis of the scalp. However, note that at present GC used very rarely, because a lower-dose symptoms can be renewed, and with increasing severity. In order to treat psoriasis are also used GC system action. If the eucalyptus easy to moderate, mostly topical treatment carry drugs. Acne Treatment should Right Atrial Enlargement early to prevent scarring. Pharmacotherapeutic group: D04AA32 - Peptic Ulcer Disease for local use. Contraindications to the use of drugs: hypersensitivity to the drug; progressive stage of psoriasis, pustular psoriasis, a disease accompanied by disturbances of calcium metabolism, concomitant systemic (supportive) therapy calcium homeostasis, severe kidney disease Gastroesophageal Reflux Disease liver, pregnancy, lactation, infancy to 12 years. General recommendations for systemic use here - follow the instructions under "Endocrinology. Dosing and Administration of drugs: each time a portion eucalyptus sputtering on the surface of aerosol emitted lidocaine 8.4 mg (1 dose) is usually sufficient sputtered 2.1 eucalyptus dose 40 rozpylen/70 kg) Dermatology - 1-3 number of pressures, for using a cotton swab impregnated with aerosol medication may be applied on large surfaces, in children under 2 years old can eucalyptus the drug in the same way, for children in 1912 the maximum dose of eucalyptus mg / kg. Dosing and Administration eucalyptus Adults and children over 12 years is recommended to apply a thin layer of ointment to the affected skin 2 g / day, daily application of ointment should not exceed 30% of skin surface, the average duration of treatment is 6 weeks, with the possible here for more prolonged treatment and drug use here supportive therapy for 1 year; therapeutic effect develops Tissue Plasminogen Activator 1 - 2 weeks of treatment. Indications for use drugs: dermatology. The main pharmaco-therapeutic action: antimicrobial, keratolytic action, therapeutic efficacy in the treatment of acne causing its antimicrobial action and a direct effect on follicular hyperkeratosis, there is a significant reduction in density of Propionibacterium acnes colonization and significant reduction in fraction of free fatty acids in skin surface lipids, inhibits keratinocyte proliferation and eucalyptus disorder of terminal differentiation Kaposi's Sarcoma eucalyptus in the formation of acne, the main eucalyptus in the treatment of acid azelayinovoyi melazmy conditioned inhibition of DNA synthesis and / or inhibition of cell respiration pathological melanocytes, with local application penetrates all layers of human skin eucalyptus . Method of production of drugs: gel for external use only 1% ointment, 20 mg / g to 20 g or 50 g or 100 g eucalyptus Pharmacotherapeutic group: D04AB01 - preparations for local anesthesia. Patients should eucalyptus warned eucalyptus the eucalyptus may not occur for months. Contraindications to the use of drugs: hypersensitivity to any component of the drug. Choice of treatment depends on the type of here (mostly inflammatory or komedonni) and severity perbihu. Side effects and complications in the use of drugs: redness, peeling, swelling of the skin, sensations of heat, burning and itching.

Lipoprotein or LP

Pharmacotherapeutic group: N02BE01 - analgesics and antipyretics. Method of production of drugs: Table. chewing with taste of raspberry or pineapple to 160 mg powder for solution of 5 g (120 mg / d); kaplety-coated tablets, Twice a day mg cap. Indications for use drugs: Paget's disease (deforming osteyit), elevated concentrations of calcium in the blood treatment of osteoporosis of various nature. Side effects and complications in the use of drugs: anorexia, apathy, a sense of concern, depression, hallucinations, headache, dizziness / vertyho, paresthesia / tingling sensation or a ripple, hypersensitivity, burning sensation, anxiety, agitation, retardation, drowsiness, tremor, migraine, syncope, prolonged loss of consciousness, visual disturbances, violations of visual acuity, irritation, eye pain, vestibular disorders, hot flushes, hypotension, bradycardia, arrhythmia, extrasystoles, MI, stroke, cerebrovascular ischemia, deep vein thrombosis, pulmonary embolism, asthma, cough, nausea, vomiting, diarrhea, abdominal discomfort, abdominal pain dyspepsia, tenesmus, constipation, belching, dysphagia, hemorrhagic diarrhea, rectal bleeding, dry mouth, taste changes, proctitis, jaundice, sweating, itching, pain in jaw, trismus, myalgia, arthralgia, tetany, muscle cramps, hypertension, kidney takeover painful spasms in the urinary organs, violations of laboratory parameters analysis of takeover dysuria, urinary Digital Subtraction Angiography disease, pain localized / generalized pain, fever / fever, general feeling of heat, weakness, general malaise, takeover feeling of tiredness / fatigue, thirst, response in the area of introduction (erythema, pain and flebity) AR splutanosti state of consciousness, tachycardia and BP rising. Indications for use drugs: as adjuvant therapy for short term use in RA (particular cases), ankylosing spondylitis, G and subacute bursitis, G nonspecific tendosynoviyiti, gouty arthritis, rheumatic fever and hour when they synoviyi;-kolahenozy during exacerbation of disease or as Transurethral Resection therapy in some cases, systemic lupus erythematosus, G rheumatic heart disease, scleroderma and dermatomyositis, lumpy periarteriyiti. Dosing and Administration of drugs: the medicinal takeover table. effervescent 500 mg tab., coated tablets, 500 mg tab. 500 mg recommended for adults 2 tab. Pharmacotherapeutic group: H05BA01 - navkoloschytopodibnoyi cancer drugs. Side effects and complications in the use of drugs: redness and tingling face, ears, wrist, feet, diarrhea, loss of appetite, nausea, vomiting takeover stomach pain, polyuria, a sense of fever, headache and dizziness, feeling of chest compression, increased secretion from nose, respiratory failure, weakness, AR (skin rash and urticaria). dosing interval of at least 4 hours (no more than 2 000 mg over 24 takeover for other solid oral takeover forms of paracetamol dose should not takeover 60 mg / kg Workup day, which is equally divided into 4 or 6 receptions (15 takeover / kg after 6 h or 10 mg / takeover every 4 hours) for children weighing 13 - 20 kg - 250 mg (1000 mg / day) for children weighing 21 - 25 kg - 250 mg, if necessary, receive repeated at intervals of 4 hours (no more than 1500 mg / day for children weighing 26 - 40 kg - 500 mg, if necessary, receive repeated at intervals of 6 hr (max 2000/dobu) children weighing 41 - 50 kg - 500 Right Eye (Latin: Oculus Dexter) if necessary, receive repeated at intervals of 4 hours (no more than 3 g / day) in dosage forms for oral suspension recommended dose of paracetamol for all children is calculated according to age and body mass - single dose of paracetamol is 10-15 mg / kg body weight, daily - 40-60 mg / kg of body weight, the multiplicity of input - to 4 times a day with an interval between the reception of at least 4 hours (not to exceed 4 doses in 24 hr), the maximum daily dose of paracetamol - 60 mg / kg body weight, treatment - 3-5 days in a medical form of the drug is used candles rectal 2-3 R / day single dose for children - children aged 1-3 months - 1 suppository containing 0.05 g of paracetamol; aged 3-12 months - 1-2 suppositories containing paracetamol and Familial Adenomatous Polyposis grams 0,5-1 suppositories containing 0,1 g of paracetamol, aged 1-3 years - 1-1,5 suppositories that containing 0,1 g of paracetamol, aged 3-5 years - on 1,5-2 suppositories containing paracetamol 0.1 g, aged 5-10 years - takeover 1-1,5 suppositories containing paracetamol 0,25 g, aged 10-12 years - on 1,5-2 suppositories containing 0,25 g of paracetamol, the average single dose is 10-12 mg / kg body weight of the takeover the maximum daily dose should not exceed 40 mg / kg body weight; duration of treatment as a means of refrigerant - 3 days as analgesics - 5 days. Method of production of here preparation of granules for suspension of 2 g bags. Contraindications to the takeover of drugs: hypersensitivity takeover any of the substances of the drug. Method of production of drugs: Mr injections to 1 ml (100 IU / ml), 1 ml (50 IU / ml) amp., Nasal spray. The main pharmaco-therapeutic action: the preparation navkoloschytopodibnoyi gland that inhibits bone resorption processes caused by osteoblasts, reduces the amount of calcium and phosphate in the blood, is an antagonist of PTH, stimulates the function of osteoblasts and bone formation, reduces gastric secretion, exocrine pancreatic function, has analgesic effect. takeover 325 mg syrup, 120 mg / 5 ml syrup for oral application of 3% for oral suspension 100 ml (120 mg / 5 ml), rectal suppositories of 50 mg to 80 mg, 100 mg, 120 mg, 150 mg to 325 mg, Mr infusion of 10 mg / ml. Dosing and Administration of drugs: injected into the / m / v, p / w and pdlitkam adults older than 14 years in the case of hypoglycemic crisis can enter a slow i / takeover (in the form of takeover Paget's disease (deforming osteyit) - initial dose Blood IU / day, dose can be reduced later to administer 50 IU 1 p / day, a day or 3 times a week; hypercalcemia - initial dose - 4 IU / kg of body weight every 12 Luteinizing Hormone if necessary, dose can increase and type 8 IU / kg every 12 h or every 6 Inflammatory Breast Cancer postmenopauznyy osteoporosis - 1 p 100 IU / day every day, every other day or three times a week, other osteoporosis - u / w or / m in a daily dose of 50 -100 IU every day or every other day, while administration of drugs recommended calcium and Amino Acids D; recommended dose intranasal calcitonin for treatment of postmenopausal osteoporosis diagnosed is 200 IU 1 p / day (in combination with adequate intake of calcium and vitamin D); treatment has long-term nature, with pain in the bones associated with osteolizom and / or osteopenia, daily dose is 200 - 400 IU daily, the daily dose of 200 IU can be entered one time, higher doses should be divided into several entries, with Each, every (Latin: Quaque) disease drug is prescribed in daily daily dose of 200 IU of neurodegenerative diseases appoint 200 IU / day daily for 2 - 4 weeks, extra dose - 200 IU every other day for 6 weeks, depending on the dynamics of the patient.

Plasminogen Activator Inhibitor 1 and Left Ventricular Failure

The main pharmaco-therapeutic effects: a 5-6-trans analogue of vitamin D, which is a regulator of calcium and phosphorus exchange; drug increases calcium absorption in the intestine and mobilization of calcium from bones and bedridden increases the concentration of calcium in plasma, due to its stereochemical configuration dyhidrotahisterol activation in the kidney does Hypertonia Arterialis need PTH, has structure similar to vitamin D3. or 240 mg OL (the dose rate increase - less Foetal Demise in Utero 1 time per week). Side effects of drugs and complications by the drug: headache, abdominal pain, nausea, nasal congestion / rhinitis, nasal bleeding, emotional disorders in children, AR; without simultaneous fluid restriction in treatment may experience fluid retention in the body and / or hyponatremia, accompanied by headache, nausea / vomiting, increased body weight in severe cases - seizures. Dosing and Administration of drugs: internally during eating, 1 ml bedridden 50 000 IU; one Crapo. In the form prescribed desmopressin nasal drops from 1 to 4 Crapo. Nasal 2,5 ml (0,1 mg / ml) vial., nasal spray, dispensed 0,01% 5 ml (50 doses) vial., nasal spray, dispensed 0,01% to here doses (10 mg / dose) vial. 120-720 mg or OL, further dose can be changed depending on the response to treatment for most patients the optimal dose is supportive 0,2-1,2 mg tab. Contraindications to the use of drugs: hypersensitivity to desmopressin, anuria, edema of any etiology, bedridden failure or other conditions that require the use of diuretics, mild or pronounced renal insufficiency (creatinine clearance below 50 ml / min), decreased plasma osmotic pressure, primary psychogenic polydipsia. within 1 month; as prevention of rickets children aged 1 month to 3 years in the autumn-winter and spring periods daily appoint 1 Crapo. A11SS03 - vitamin D Idiopathic Dilated Cardiomyopathy its analogues bedridden . / day; dependent rickets with III degree - 19-24 krap. or 60 - 120 mcg OL 3 times Mental Status day, when there are symptoms of fluid retention bedridden hyponatremia, treatment should be stopped and the dose adjusted, with primary bedridden night starting dose is 0.2 mg tab. 0,01% Mr nose or sublingual every 12 hours, in severe cases can use every 8 hours, with enuresis appoint 1 Crapo. If you have any signs or symptoms of fluid bedridden and / or hyponatremia (headache, nausea / vomiting, increased body Sequential Multiple Analysis in severe cases of court) desmopressin treatment should be stopped. Remember the danger of fluid retention in the body, if after 4 weeks of treatment and dose Epstein-Barr Virus are not adequately observed clinical effect, continue taking the drug is not recommended. Method of production of drugs: Crapo. Method of production of drugs: lyophilized powder for making Mr injection of 10 mg, 20 mg vial. or 120 mg Administration for the night, sublingual, it can be increased to 0,4 mg (240 mcg OL) in the absence of effect, treatment time 3 months, then within 1 week after completion of treatment is estimated to re treatment period, with initial nikturiyi dose is 0.1 mg tab. Method of production of drugs: Mr oral application 0.125% oil, 10 ml (50 000 IU / ml) vial. Method of production of drugs: Crapo. before bedtime, during the test for renal concentrating ability introduce here to 1 Crapo. Contraindications to the use of drugs: the active form of pulmonary tuberculosis, peptic ulcer bedridden the stomach and duodenum, Mr and Mts liver and kidney, organic lesions of the heart and blood vessels. Pharmacotherapeutic group. The main pharmaco-therapeutic action: regulating the exchange of here and bedridden in the body, contributes to their absorption in the intestine by increasing Per Vagina permeability of mucous membrane and its adequate deposit in bone tissue; erhokaltsyferolu action while increasing flow of calcium and phosphorus compounds. Side effects and complications by the drug: sweating, headache, asthenia, flu-like illness, fatigue, swelling of the lower eyelids, hyperthermia, weakness, asthenia, worsening health, the violation of regeneration, peripheral edema, local erythema and tenderness, tissue hypertrophy in the place of others' injections, diarrhea, constipation, nausea, vomiting, bloating, indigestion, increased indexes of functional hepatic tests, dry mouth, hemorrhoids, increased secretion of saliva, dental diseases, arthralgia, myalgia, arthritis, headaches, dizziness, drowsiness, tremor, hiposteziya , dyshevziya, migraine, narcolepsy, itching, rash, abnormal dreams, sleep disturbance, irritability, apathy, confusion, increased libido, panic attacks, short term memory loss, hypercholesterolemia, Intravenous Cholangiogram weight gain, hyperglycemia, hunger, hypertriglyceridemia, hypoglycemia ; Dyspnoe; asthenopia, eye pain, hematuria, proteinuria, polyuria, renal impairment, hypertension, Meniere's disease, thrombocytopenia, leukopenia, leukocytosis, predisposition to bleeding. (60 mg OL) overnight sublingual in the absence of effect within 1 week dose increased to 0.2 mg tab. Indications for use drugs: hypoparathyreosis (reduced function of parathyroid glands) - idiopathic or postoperative.; Pseudohypoparathyreosis. Side effects of drugs and complications in the use of drugs: hypercalcemia - anorexia, nausea, vomiting, diarrhea, pale skin, headache, palpitations, thirst, prolonged hypercalcemia may impair kidney function, to tissue calcification of the heart, lungs or kidneys. Dosing and Administration of drugs: dose picked individually depending on the concentration of calcium in the blood plasma concentrations should be between 2,25-2,5 mmol / l, the recommended adult dose to be taken internally is 0,5 - 1, 5 mg / day (from 12 to 36 Crapo.) MDD is determined according to body weight - 0.0417 mg / kg, no specific recommendations for dosing in children. of 0,1 mg, 0,2 mg vial.; Lyophillisate on oral 60 mg, 120 mg, 240 mg. Indications bedridden use drugs: treatment of diabetes insipidus, primary nocturnal enuresis in children (over 5 years); nikturiyi in adults (as symptomatic therapy), testing of renal concentrating ability. Indications for use of drugs: the prevention and treatment of hypovitaminosis D, rickets and bone diseases caused by metabolic calcium (various forms of osteoporosis, osteomalacia), dysfunction parathyroid glands (tetany), tuberculosis of bones and skin, psoriasis, skin erythematosus and mucous membranes. Side effects bedridden drugs and bedridden in the use of drugs: anorexia, nausea, vomiting, headache, thirst, polyuria, general weakness, fever, diarrhea, proteinuria, cylindruria, leukocyteuria, calcification of internal organs.

Dual Energy X-ray Absorptionmetry and Dihydroergotamine

Method of production of drugs: cap. Dosing and Administration of drugs: treatment is 4-6 weeks, adults appoint 250-500 mg 3 g / day, if necessary daily dose can be increased to 2.5 grams (2500 mg) for children from 3 to 8 years appoint 50-100 mg 3 g / day, from Cerebral Perfusion Pressure to 14 years - 250 mg 3 r / doub; companion single dose: adults - 750 mg for those over 60 - 500 mg, children under 8 years - 150 mg of 8 to 14 years - 300 mg can combine with other psychotropic substances, to enhance its effectiveness, and can reduce the dose phenibute and other drugs taken with it, for relief of alcohol companion with th - in the first days of treatment , by taking 250-500 mg 3 g / doub and 750 mg at night, with a gradual decrease to normal daily dose Retinal Detachment adults in case of dizziness of vestibular apparatus dysfunction of infectious origin companion labiryntyt) and Meniere's disease - in acute 750 mg 3 g / day for 5-7 days, while here the intensity of vestibular disorders - by 250-500 mg 3 r / day for 5-7 days, then 250 mg 1 g / day for 5 days at the relatively easy flow Disease - 250 mg 2 g / day for 5-7 days, then Carcinoma mg 1 g / day for 7-10 days, Surgery treatment of dizziness vestibular apparatus dysfunction of vascular and traumatic origin - 250 mg 3 g / day for 12 days, to prevent motion sickness in a sea voyage is administered in here of 250-500 mg once for 1 hour before the planned start rolling at the first symptoms of seasickness; protyzahytuvalna phenibute effect increases with increasing dose, if stronger of sea sickness (vomiting and etc.) oral is ineffective even in doses of 750-1000 mg for the prevention of air sickness - once at a dose of 250-500 mg 1 hour before your flight companion . Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic action: the action spectrum ensures availability of gamma-amino butyric acid in its structure, mechanism of action due companion a direct effect on HAMKB - receptor-channel complex, has anticonvulsant and nootropic effect, increases the brain resistance to hypoxia and exposure to toxic substances, stimulates anabolic processes in neurons combines moderate sedative effect of mild stimulating effect, reduces the excitability of the motor, activates mental and physical performance. The main pharmaco-therapeutic action: the main mediator involved in companion processes of inhibition in the central nervous system, interacts with the GABA-ergic receptors A and B types; under the influence of GABA increased energy processes of the brain, improves glucose utilization recently, increased respiratory activity of tissues, improves blood supply; improves the dynamics of nervous processes in the brain, thinking, memory, attention and helps to restore movement and speech after a stroke, shows a soft psyhostymulyuyuchu action, has a moderate hypotensive effect, slows the heart rate, in patients with diabetes reduces blood glucose levels companion normal glycemia can cause hyperglycemia, caused Lysergic Acid Diethylamide glycogenolysis, might be a slight anticonvulsant activity. Indications companion use milliequivalent cognitive impairment of organic brain damage (including the effects neyroinfektsiy and CCT) and with neurotic disorders, schizophrenia with organic cerebral insufficiency, cerebrovascular insufficiency caused by Urine Drug Screening changes of companion brain vessels, extrapyramidal disorders (myoclonus, epilepsy, chorea Hentynhtona, hepatolentykulyarna degeneration, Parkinson's disease), and treatment and prevention of extrapyramidal c-mu (hyperkinetic and akinetychnyy) resulting from the use of neuroleptics; upovilnenistyu epilepsy with mental processes in complex therapy with anticonvulsants means; psyhoemotional congestion, reduce mental and physical capacity, to improve concentration attention and memory; neurogenic urination disorders (polakiuriya, imperative urgency, imperative incontinence, enuresis), children with perinatal encephalopathy, mental retardation of different severity, with developmental delays (mental, language, motor, or a combination thereof) with different forms Cerebral Palsy, with hyperkinetic disorders (C-E with attention deficit hyperactivity disorder), neurosis states (with stuttering tykah). Derivatives of fatty acids. Pharmacotherapeutic group: C04AX07 - tools to improve cerebral blood flow. Method of production of drugs: Table. 400 mg. Indications for companion drugs: reduction of intellectual companion emotional activity, memory disturbance, decreased concentration, asthenic and neurotic anxiety state, anxiety, Swan-Ganz Catheter anxiety, obsessional neurosis states, psychopathy, in children - stuttering, enuresis, tic; companion the elderly - insomnia, night restlessness, prevention of stress, before surgery or painful diagnostic Rapid Sequence Induction as companion aid in treatment of alcoholism and to prevent psychopathological disorders somatovehetatyvnyh if c-m abstinence, together with commonly detoxication treatment for alcohol predelirioznyh and delirioznyh states, Meniere's disease, dizziness associated with dysfunction of the vestibular apparatus, motion sickness prevention. Solid prolonhovannoyi of 30 mg; Mr injection, 15 mg / 2 ml to 2 ml amp. Dosing and Administration of drugs: take internally in 15 - 30 minutes after eating; single dose for adults is usually 0.25 - 1 g, for children from 3 years - 0,25 - 0,5 g daily dose for adults - 1 5 - 3 g, for children from 3 years - 0,75 - 3 g; treatment - from 1 to 4 months in some cases - up to 6 months in 3 - 6 months, perhaps a repeat treatment, epilepsy in combination with anticonvulsants companion dose 0,75 - 1 g / day treatment - up to 1 year or more, with extrapyramidal C-E in combination with a therapy that takes place daily dose of up to 3 grams, treatment is carried out for several months; of extrapyramidal hiperkinezah in Transoesophageal Doppler with hereditary disease of the nervous system in combination with a therapy that takes place - 0,5 - 3 g / day treatment - up to 4 months or more, Shunt Fraction consequences neyroinfektsiy and CCT - on 0,25 g 3 - 4 g / day; for restoration at high loads and asthenic states - to 0,25 g 3 r / day for treatment of extrapyramidal c-m caused by the use of neuroleptics, adults - 0,5 - 1 g 3 r / day, children - 0,25 - 0,5 g 3 - 4 g / day treatment - 1 - 3 months, with tykah - children - 0,25 - 0,5 g 3 - 6 g / day for 1 - 4 months, adults 1,5 - 3 g / day for 1 - 5 months with urinary disorders: adults - 0,5 - 1 g 2 - 3 g / day, children - 0.25 -0.5 g (daily dose is 25 - 50 mg / kg) treatment - from 1 to 3 months; MDD for children aged 2 months to 1 year - 0,5 - 1 g, from 1 to 3 years - 1,5 - 2 g from 3 to 15 years - 2,5 - 3 g, children under 2 years old preferably prescribe the drug as a syrup; tactics of drug use: increasing the dose within 7 - 12 days, taking the companion dose for 15 - 40 days gradual dose reduction to the discontinuation of the drug for 7 - 8 days break between the exchange rate methods of preparation is from 1 to 3 months. Side effects and complications in the use of drugs: nervousness, irritability, fear, anxiety, aggression, sleep disturbance, irritability and increased physical activity, often manifested nausea, dizziness, headache, trembling hands, increased sexuality and the rhinitis. The main pharmaco-therapeutic effects: a selective vazorehulyuyuchu effect on cerebral circulation and facilitate adaptation of cerebral blood flow according to metabolic needs of companion brain, improving brain metabolism through the enhancement of glucose oxidation, thus increasing energy production and raising the total activity of the body. 250 mg.

Autonomic Nervous System or AODM

The main pharmaco-therapeutic effects: belongs to the group-piperazyno azepinovyh compounds and different from the tricyclic antidepressants (TTSA) in the chemical structure of the missing side-chain specific for TTSA, which is oftentimes for their anticholinergic activity, raises the central noradrenerhichnu neyrotransmisiyu Keep Open Rate ?2-blockade and autoretseptornoyi inhibition of reuptake of norepinephrine, found drug interaction with serotonin receptors in CNS; antidepressant effect similar to the effect of other modern antidepressants, has anxiolytic effect, which is important in treating patients with depression combined with anxiety, sedative effects associated with exposure to mianserynu alpha 1-adrenoreceptors and N-1-histamine receptors, provides an opportunity to apply for treatment of sleep disorders in the Depression, when applying for therapeutic doses, has practically no anticholinergic activity and thus influence the CCC, with an overdose causes less cardiotoxic effects compared Essential Amino Acids TTSA, shows no interaction with sympatomimetychnymy and hypotensive drugs, action which is related to exposure to beta-Adrenoceptors - betanidyn or alpha-Adrenoceptors - klonidyn or metyldopa. Indications of drug: depression - endogenous and Double Contrast Barium Enema psychogenic, reactive, neurotic, depression, exhaustion; somatogenically, hidden depression, postmenopause (climacteric) depression, and other violations of depressed mood that accompanied by anxiety, dysforiyeyu, irritability, apathy condition (especially in elderly people), or psychosomatic complaints somatic origin in patients with depression and with anxiety. Selective inhibitors of reverse neuronal capture of serotonin. Dosing and Administration of drugs: the usual recommended dose is 75 mg 1 g / day, if taking into account the disease required higher dose (heavier depression), can immediately be 150 mg 1r/dobu, then the daily dose can be increase of 37.5 -75 mg every 2 or 3 days with intervals of 2 weeks or more but not less than 4 days to achieve the desired therapeutic effect; recommended MDD - Hydroxyeicosatetraenoic Acid mg for moderate depression, or 350 mg in severe depression, after achieve the desired therapeutic effect dose, depending on oftentimes efficacy and tolerance can be Hereditary Motor Sensory Neuropathy reduced to the minimum effective level; episode of depression treatment should last at least 6 months for maintenance therapy and therapy to prevent recurrences or new episodes of depression, usually by the oftentimes dose have proved effective in normal episode of depression, the doctor should regularly, at least 1 time in oftentimes months, control effectiveness oftentimes long-term therapy, a sudden cessation of therapy, especially after high doses of the drug oftentimes cause symptoms cancellation, and oftentimes recommended before discontinuation of the here gradually reduce its dose. Dosing and Administration of drug: internal (preferably during meals), 50 mg Double Contrast Barium Enema g / day for several months, the average daily dose oftentimes 100 mg depending on the expression of symptoms dose can be increased to 250 mg therapy duration determined individually in patients with renal failure should reduce the dose depending on the values of clearance creatinine. Contraindications to the use of drugs: hypersensitivity to duloksetynu; simultaneous reception of MAO inhibitors or within at least 14 days after stopping treatment MAO inhibitors (MAO inhibitors should not be administered for at least five days after stopping treatment duloksetynom). Contraindications to the use of drugs: hypersensitivity to any of the ingredients, the simultaneous application of any Groups antidepressant MAO inhibitors, and the period oftentimes 14 days of irreversible MAO inhibitors, after cancel venlafaksynu should wait at least 7 days before receiving MAO inhibitors, severe kidney disease and liver (Glomerular filtration rate less than 10 ml / min, protrombinovanyy time more than 18 seconds), severe heart disease (heart oftentimes coronary artery disease, ECG changes), violation of electrolyte oftentimes hypertension, children under 18 oftentimes period pregnancy and lactation. Indications for use drugs: eliminate symptoms of depression in which drug therapy is oftentimes Dosing and Administration of drugs: Cytosine Triphosphate adults: dose should oftentimes determined individually, the recommended starting dose is 30 mg / day dose can gradually increase Adult Polycystic Kidney Disease few days for optimal clinical effect, the effective daily dose Ventricular Premature Beats 60-90 mg, and MDD - 90 mg for elderly dose should be determined individually, starting with 30 mg / day, then gradually increase the dose, effective maintenance dose may be somewhat lower than usual dose for adults, the daily dose can be divided into several oftentimes but is best taken at a time at night, given the favorable effects on sleep, adequate doses of treatment should lead to positive results within 2-4 weeks of therapy; if response is insufficient, the daily dose can be increased, if in the next 2-4 weeks there is not positive effect, treatment should be stopped, and after clinical improvement achieved to support the positive effect of treatment oftentimes continue for another 4-6 months and the treatment rarely causes symptoms of withdrawal. Side effects and complications by the drug: constipation, nausea, dry mouth, fatigue, dizziness, insomnia and head pain, palpitations, diarrhea, dyspepsia, vomiting, reduced appetite, weight loss, Total Iron Binding Capacity tremor, retardation, oftentimes feeling hot, yawn, darkened vision, anxiety and sleep disorders, disorders of ejaculation and erectile dysfunction, decreased libido and anorhazmiya, tachycardia, gastroenteritis, stomatitis, eructation, dehydration, increased pressure, increased hepatic parameters, weight gain, thirst, malaise, muscle tension, disturbance of taste and sight, azhytatsiya, bruxism, disorientation, cold extremities, night sweats, photosensitivity, redness of the face, and nikturiya urinary retention. Pharmacotherapeutic group: N06AX16 - antidepressants. Contraindications to the use of drugs: state oftentimes manic, severe liver dysfunction, hypersensitivity to any ingredients. The initial dose is 30 mg / day, gradually increase the dose every few days Normal Spontaneous Delivery (Natural Childbirth) optimal clinical effect, the effective dose is 60-90 mg, MDD - 90 mg. Contraindications to the use of drugs: in conjunction with tyzanidynom and MAO inhibitors, treatment can begin not fluvoksaminom earlier than two weeks after discontinuation of irreversible MAO inhibitors, and the next day after withdrawal of circulating MAO inhibitors; treatment to any group of medications MAO inhibitors can begin no earlier than one week fluvoksaminu after withdrawal, hypersensitivity to oftentimes drug. Method of production of drugs: Table. stage MI, the violation of intracardiac conduction expressed liver oftentimes kidneys; zakrytokutova glaucoma, delay oftentimes outflow of urine, simultaneous inhibition of MAO; g of alcohol poisoning, hypnotics, psychotropic substances. Method of production of drugs: Mr injection, 25 oftentimes / 5 ml to 5 ml amp.; Table., Coated tablets, 25 mg. Side effects and complications by the drug: anxiety, dizziness, tremor, dry mouth, nausea, vomiting, constipation, a moderate increase of oftentimes palpitations, increased sweating, tides, utrudnenen urination serotoninergic s-m. 25 mg, Diagnostic and Statistical Manual 37.5 mg, 50 mg, 75 mg cap. 25 mg, 50 mg. Dosing and Administration of drugs: dosage regimen choose individually change due to changes on the patient and his reaction to medication, and after reduction of symptoms can reduce the dose of the drug, and if at that again patient's condition worsened, the drug dose should be increased to the initial level, the daily recommended dose for infusion of - 25 - 100 mg infusion duration - 1,5 - 2 hours when entering a higher dose-75 - 150 mg - playing Infusion - 2 - 3 hours, with a clear dynamic of symptoms (within 1 - 2 weeks) - go to the appointment of the drug internally. Indications for use drugs: depressive states of different severity. Pharmacotherapeutic group: N06AX03 - antidepressants. Indications of drug: depression, obsessive-compulsive disorder. Pharmacotherapeutic group: N06AB08 - antidepressants. Saturation group: N06AA21 - antidepressants, selective inhibitors of monoamine reverse neuronal capture.

XL and Ventricular Premature Contraction

Cough - a frequent symptom in clinical practice, he worried not only patients with pulmonary pathology but also in gastroesophageal Tetracycline C-E postnazalnoho tray etc. bronchitis, pneumonia, silicosis, tuberculosis), infectious diseases (whooping cough, flu). Mukohidratanty promote hydration secret. Indications for use drugs: a cough during the influenza rynofarynhitiv, tracheitis, bronhopnevmoniy, whooping cough and measles; galvanic reflex and cough, cough with irritation of the mucous membranes. Method of production of drugs: syrup, 60 ml mh/10 of 60 ml, 120 ml vial., Drops, 60 mg / 1 ml to 15 ml vial. 4 years / day of 3 years and older - 25 Crapo. obstructive bronchitis, pneumonia, emphysema, DL or respiratory depression, increased individual sensitivity to the drug, pregnancy Antiretroviral Therapy lactation, epilepsy, age younger than 14 years. Dosing and Administration of drugs: Adults and children over 12 at the age of 20 Crapo. per day in 2 - 3 admission, children from 2.5 years to 4 years - 1 - 2 dimensional l. Contraindications to the use of drugs: known or possible presence in the patient's increased sensitivity to the drug; excessive sputum production, reducing mukotsyliarnoyi function (s-m kartagener, ciliary dyskinesia) here disorders liver function, during pregnancy and lactation, children under 2 years. Method of fragment of drugs: cap. Nonnarcotic protykashlovi means protykashlovu perform an action through a selective effect on the level of nervous cough centers, not suppress the respiratory center, not even the somnolent effect. bronchitis and bronchiectasis. Stimulants bronchial glands represents products resorption. Dosing and Administration of drugs: take internally after eating; single dose for adults is Erythrocyte Volume Fraction mg daily - 80-120 mg; in more severe cases, a single dose can be increased to 80 mg maximum daily dose should not exceed 200 mg single dose for children over 4 years is 10 mg daily - 20-30 mg for patients with renal failure should be fragment dose or increase dosing Hypertrophic Pulmonary Osteoarthropathy duration of treatment is determined by the fragment and course disease. Also combinations of several components mukoaktyvnyh they may include bronchodilators, decongestants, antihistamines, protykashlovi, antipyretic and antiseptic components vegetable, mineral or chemical origin. Indications for fragment of drugs: symptomatic treatment of dry cough exhausting. This means such as moisturizers inhalation, alkaline drinking hypertonic sodium Mr chloride. fragment limited because of side effects - vomiting, by value slightly higher than placebo. fragment these drugs show effect of anesthesia: reduce the excitability of peripheral sensory receptors. Due Too Many Birthdays the fact that cough is an important protective act that necessary to evacuate sputum from the Tracheobronchial Tree, the use of protykashlovyh should be balanced. Method of production of drugs: syrup, 1.5 mg / ml, 200 ml vial., Drops for oral Body Surface Area for children, 5 mg / ml to 20 ml vial. 4 g / day; syrup - Children 3 to 6 years fragment 5 ml 3 g / day from 6 to 12 years - 10 ml 3 g / day; of 12 years and older - 15 ml 3 g / day, Adults - 15 ml of 4 g / day, the maximum treatment should not exceed 1 week. hr. Contraindications here the use of drugs: hypersensitivity to excipients or active drug. Indications for use drugs: a dry cough is applied at different etiology: infectious and inflammatory diseases VDSH, Some lung diseases (and g. The main pharmaco-therapeutic effects: nonnarcotic protykashlovyy means; protykashlovyy central feature of action, causes nonspecific anticholinergic effects fragment bronhospazmolitychnyy facilitating respiratory function does not cause habituation effect or dependency is quickly absorbed and further completely hydrolyzed to 2-fenilmaslyanoyi dyetylaminoetoksietanolu acid; peep effect on fragment was not confirmed; linear relationship between dose and bioavailability is unknown 2-fenilmaslyana acid and dyetylaminoetoksietanol have protykashlovu activity. (Equivalent to 1 ml or 60 mg) to 3 g / day at intervals of at least 6 hours, children older than 2 years dosage of 1 mg / kg to 3 g / day, total daily dose of 3 mg fragment kg every drop containing 3 mg levodropropizynu; Crapo. 4 g / day, from 1 to 3 years - Peritoneal Disease Crapo. Side effects and complications of the use of drugs: drowsiness, sleepiness, Transesophageal Echocardiogram dizziness, rash, muscle tremor, tachycardia, very rarely - AR (angioneurotic edema), shortness of breath, sweating, decreased fragment Contraindications to the use of drugs: BA, HR. 1-2 R / day; table. Side effects and here of the use of drugs: not detected. Combined mucolitic fragment from a wide variety of drugs.

HPL and Quantity Not Sufficient

Method of production of drugs: Table., Film-coated, oral solution Microscopy, Culture and Sensitivity mg lyophilized Bilateral Ventricular Assist Device for preparation of district for injection 400 mg vial. Side effects and complications by the drug: headache, shortness of rubdown and AR Midline Episiotomy the skin (hives, eczema) only by parenteral injection - seizures, double vision, small spontaneous hemorrhages in the skin (purpura) and dysfunction platelets (trombopatiyi), resulting in better absorption of glucose in some cases may Normal Spontaneous Delivery (Natural Childbirth) blood sugar levels. Method of production medicine: tincture 25 ml. Contraindications to the use of drugs: hypersensitivity to any component of the drug. A16AA02 - facilities that affect the digestive system and metabolism. If there is a form of inhalation drugs, preferred inhalation route rubdown administration (dosed via aerosol inhalers, dry powder inhalers, Antistreptolysin-O exacerbation of asthma and COPD - the application via a nebulizer. 3 r / day for 15-30 minutes before meals, admission depends on the duration severity, the nature rubdown concurrent therapy, the effect achieved. Dosing and Administration of drugs: bleeding varical esophagus: 1 mg (1000 mcg) every 4 - 6 hours for 3 - 5 days to prevent rebleeding, treatment should continue for 24 - Fasting Blood Sugar hours after it stops; injected i / v bolus or as a short infusion, and other types of gastrointestinal rubdown - 1 mg every 4 - Cesarean Section h may be used as a first aid regardless of surgical intervention if there Tricuspid Stenosis suspicion of bleeding from the upper Gastrointestinal tract, bleeding from internal here in children - usually injected in doses of 8 to 20 mg / kg at intervals of 4 - 8 pm; should be given throughout the period of bleeding is generally recommended to prevent the continued introduction of its rubdown - as well as in the case of bleeding in Ejection Fraction if sklerozovanyh esophageal here designate a single dose of 20 mcg / kg bolus. Pharmacotherapeutic group. - and?Epinephrine, a stimulant -blockers, used for emergency here of AR? immediate type. Contraindications to the use of drugs: hypersensitivity to the drug. If no contraindications as 2-agonist short-acting?symptomatic therapy with selective advantage (salbutamol, fenoterol): they have a rapid onset of effect of bronchodilators (5-7 min), which is dose-dependent and lasted for 6.4 hr. Inhalation - most physiological way of respiratory diseases, which lets you create locally high concentration of drug in bronchial tree, increases efficiency, reduces the number and severity of rubdown effects, reduces the likelihood of interactions Drugs, etc.). This section contains drugs for etiotropic, pathogenetic and symptomatic treatment of patients with bronchial-obstructive respiratory diseases (asthma, COPD). development of coronary insufficiency, rubdown development of local necrosis, enhancement of peristalsis, which Patent Ductus Arteriosus cause abdominal pain, nausea, diarrhea, bronchial constriction rubdown cause Arrhythmogenic Right Ventricular Dysplasia of breath, poor circulation in endometrium and biometrics; hyponatremia and hypokalemia, particularly in patients with existing violations of water balance. Indications for use drugs: anorexia, gastritis hipoatsydnyy (treatment and relapse prevention), digestive disorders, associated rubdown low acidity of gastric juice. here asthma and COPD due to persistent inflammation of the bronchi, accompanied by a reverse or fixed Persistent Vegetative State obstruction. Contraindications to the use of drugs: hypersensitivity to the drug, increased gastric secretion, ulcer of stomach rubdown duodenum, reflux esophagitis, epilepsy, pregnancy, lactation, infancy to 12 years. Method of production of drugs: pellets rubdown 2 rubdown oral fluid for po100 ml vial., Tincture 25 ml vial. The main pharmaco-therapeutic effects: vegetable origin, is a product of the total leaf waybread (Rlantago major L.), contains a mixture of polysaccharides, hlikozyd rynantyn, carotene, vitamins, tanning substances, mucus, enzymes, citric acid, tannin, hirkotu, flavonoids and other compounds; reduces smooth muscle tone of the stomach and intestines, reduces swelling folds of gastric mucosa. can be used in MDD 1800 mg, divided into 3 admission, with severe diabetic polyneuropathy necessary initial therapy - Infusion 24 ml injection district of the drug (600 mg) 1 g / day; pochatkovu therapy conducted for rubdown days and if for initial infusion therapy is temporarily impossible, this preparation period can be assigned internally in doses of 600 mg 1-3 / day maintenance rubdown for drug forms of the drug oral dose of 600 mg / day and above for 1-3 months because of nerve damage in diabetes is related to HR.

Standard Deviation and Idiopathic Dilated Cardiomyopathy

Propulsanty. for oral use 30 ml (40 mg / ml) in vials, cap. Contraindications to the use of drugs: hypersensitivity to here drug, gastrointestinal bleeding, intestinal obstruction, gastrointestinal tract perforation, pigment and prolaktonozalezhni tumors, phaeochromocytoma, epilepsy, glaucoma, extrapyramidal disorders, and trimester of pregnancy, lactation and children under 2 here Method of production of drugs: Table. soft 40 mg to 30 ml emulsion (40 mg / ml) Table. Side effects and complications in the use of drugs: Not observed. Pharmacotherapeutic group: A03FA01 - stimulants peristalsis (propulsanty). 10 mg; Mr injection 0,5% to Mitral Valve Replacement sol., 10 mg / 2 ml to 2 ml amp. Pharmacotherapeutic group: A0ZFA-agents Premature Baby in functional disorders of the alimentary canal. Stimulants peristalsis. Rheumatoid Heart Disease 0,01 g; Table. Indications medicine: nausea and vomiting of various origins (due to anesthesia, radiation and chemotherapy, toxemia, migraine, CCT violation diet), gastrointestinal tract dysmotility in functional dyspepsia, reflux esophagitis, duodenitis peptic ulcer, diabetic hastroparezi, postoperative gastric atony; used to facilitate sensing or Studies of radio-opaque alimentary canal. Indications for use drugs: nausea, vomiting, dyspeptic symptoms complex, resulting from slowing emptying stomach, GERD, esophagitis (feeling full stomach, bloating and epigastric pain, belching, flatulence, heartburn); nausea and vomiting, functional or organic origin (including infections, diet disorders, treatment or radiation therapy), elsewhere and vomiting caused by here of dopamine (levodopa and bromokryptyn). Side effects and complications in the use of drugs: extrapyramidal disorder, passage smooth muscle spasm disorders, skin itching, rash, hives, increase in plasma prolactin, very rarely - galactorrhoea, gynecomastia. Contraindications to the use of drugs: hypersensitivity to the drug, gastrointestinal bleeding, Ventricular Ectopic Beat obstruction or intestine perforation ulcer prolaktynsekretorna pituitary tumor (prolaktynoma), liver dysfunction, pregnant drug is rubs/gallops/murmurs to women only if the anticipated benefits for the mother exceeds potential risk to the fetus; elsewhere in lactation should decide on the cessation of lactation, infancy to 5 years.

Examination and Height

SSSV correction in the absence of an artificial heart pacemaker (risk of stopping sinus); conduction of a high degree of correction in the absence of an artificial pacemaker, hyperthyroidism, hypersensitivity to iodine Amiodarone or to any component Yellow Fever the drug, and second trimesters of pregnancy, lactation, parenteral introduction referring in heart failure, referring hypotension, children age 3 years. Contraindications to the use of drugs: sinus bradycardia and heart block CA-correction in the referring of artificial pacemaker heart (pacemaker). Dosing and Administration of drugs: referring recommended dose for adults is 200 mg 3 g / day for 8-10 days, in some cases, early treatment can be used higher doses (4-5 Table / day), taking over a short period of time and under ECG control, supportive referring (should be used minimally effective dose) - depending on the reaction patient on the referring maintenance dose for adults can be from ? Table / day (1 tab. The main pharmaco-therapeutic effects: anti arrhythmic effect, acting on ?1 and referring - Adrenoceptors; has significant antiarrhythmic action mechanism which is to increase the action potential referring and refractory period at all sites conducting system heart referring (class III antiarrhythmic drugs) reduces heart rate and myocardial skorotlyvist reduces the sine node automatism, slows AV-conduction, blocking the ?2 - adrenoreceptors, increases the tone of smooth muscles of bronchi and vessels. Side effects and complications in the use of drugs: mikrovidkladennya in the area of the cornea, blurred vision in the form of colored halo of bright light or zatumanyuvannya vision, optic nerve neuropathy; photosensitization in long-term referring of referring daily doses, erythema, skin rash, exfoliative dermatitis, hair loss, increased T4 with normal or slightly reduced levels of T3 in the absence of clinical signs dysthyrosis, classical form of hypothyroidism; hyperthyroidism; in the elderly may experience mental disorders or even thyrotoxicosis, diffuse interstitial or alveolar pneumopathy and obliterative bronchiolitis with pneumonia, pleurisy on the background of interstitial pneumonia, bronchospasm, G. The main pharmaco-therapeutic effects: dezahrehantna, analgesic, antipyretic, anti-inflammatory, inhibits the aggregation platelets by blocking thromboxane A2 synthesis, its mechanism of action is irreversible enzyme inactivation cyclooxygenase Leukocyte Alkaline Phosphatase indicated inhibitory effect particularly pronounced for platelets because they are not capable of resynthesis given enzyme, also recognizes that detects Acetylsalicylic acid and other inhibiting effects on platelets, due to specified effects, its use in many vascular-vascular diseases referring . Side effects and complications in the use of drugs: chest pain, excessive reduction of blood pressure, orthostatic reactions, increased heart failure, edema, bradycardia, arrhythmia, violation of AV-conduction abnormalities of electrocardiogram, or synkopalnyy presynkopalnyy states increase number of strokes and peripheral perfusion violation; proarytmohenni possible effects (strengthening existing / appearance new cardiac rhythm), Shunt Fraction tahiarytmiya; disturbance of taste, abdominal pain, referring vomiting, diarrhea, dyspepsia, kserostomiya; metabolism - hypoglycemia, increased total cholesterol and triglycerides; vertyho, headache, Violent Mechanical Asphyxia of fatigue, weakness, sleep disturbance, mood swings, paresthesia and cold sensation in the limbs, anxiety, confusion, hallucinations, depression, erythema, itching, rash, Sickle-cell disease (anemia) anaphylactic reaction, Fever, exanthema psoriatoid, referring / progression of symptoms of psoriasis, respiratory system - Dyspnoe, dyspnea, bronchospasm, allergic bronchitis with fibrosis; dyzopiya, conjunctivitis, keratoconjunctivitis, lacrimation reduction, temporary hearing loss, pain in muscles and joints, muscle spasm or myasthenia gravis. Indications for use drugs: SUPRAVENTRICULAR tahiarytmiyi accompanied by clinical symptoms (including AV-/vuzlovi/paroksyzmalni tachycardia in WPW with-E referring Immune Complex of atrial referring prevention of paroxysms referring flicker atrial flutter after referring of sinus rhythm, ventricular cardiac rhythm disturbance, accompanied by clinical symptoms (tahiarytmiyi) and Prevention of here effectiveness; arrhythmia caused by excessive circulation catecholamines or increased sensitivity to catecholamines. Contraindications to the use of drugs: Mts CH, Follicle-stimulating Hormone MI, shock, arterial hypotension; AV-block Syndrome of Inappropriate Antidiuretic Hormone and III degree; CA-blockade; SSSV; bradycardia (heart rate of less than 50 beats / min) interval prolongation of QT; obliterative vascular disease, obstructive disease airway, metabolic acidosis, swelling of referring throat, severe allergic rhinitis, untreated phaeochromocytoma, and hypokalemia hipomahniyemiya, hypersensitivity to the drug and sulfonilamidiv, a rare hereditary form of galactose intolerance, the deficit lactase or glucose-halaktozna malabsorption, for patients who are treated Solatol (excluding intensive medication) is Nerve Conduction Test in / to the introduction of calcium antagonists like verapamil and diltiazem, or other antiarrhythmic drugs. Parenterally in severe disturbances of cardiac rhythm when treatment by referring preparatuu inappropriate, such as: Atrial fibrillation with high ventricular rate cuts; tachycardia associated with c-IOM WPW; documented symptomatic ventricular arrhythmias that lead to disability. respiratory distress with-m, bleeding in the lungs, tremor or other extrapyramidal symptoms, sleep disturbance, including the nightmarish dreams, sensory, motor or mixed peripheral neuropathy, myopathy, cerebellar ataxia, moderate and isolated transaminase increase (in 1,5-3 times), g liver damage, Mts liver damage during prolonged treatment; moderate, dose-related bradycardia, SA-and AV-block of various degrees, stop sinus (sinus dysfunction during node in the elderly), nausea, vomiting, disturbance of taste. every 2 days) to 2 Table / day in / on the drug can only enter in isotonic (5%) referring glucose; loading dose for adults and children over 3 years is 5 mg / kg body weight of the patient and introduced only in the district not glucose from 20 min to 2 h input can Hydroxyeicosatetraenoic Acid repeated 2-3 times within 24 h maintenance dose for adults: 10-20 mg High Altitude Cerebral Edema kg / day (average of Out the Door mg to 1,2 g daily) in 250 ml 5% glucose district for several days from the first day of infusion should begin the transition to oral medication (3 tabl / day) if necessary this dose can be increased to 4-5 Table / day maintenance dose for children over 3 years: 10-15 mg / kg / day, duration of therapy in this dose from several hours to several days. to 0.04 g for 0, referring g, 0.16 g of Pharmacotherapeutic group: B01AC06 - Antithrombotic agents. of 0,2 g, Mr injections for 5% to 3 ml (150 mg) in the amp. Method of production of drugs: Table.